Global Health Limited (MEDANTA.NS)
INR 1275.4
(0.43%)
INR 1275.4
(0.43%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 8.71 Billion INR | 31.88% |
| 2022 | 6.78 Billion INR | 38.99% |
| 2021 | 4.79 Billion INR | 110.5% |
| 2020 | 2.28 Billion INR | -2.92% |
| 2019 | 2.35 Billion INR | 38.53% |
| 2018 | 2.22 Billion INR | 19.32% |
| 2017 | 1.45 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.91 Billion INR | 0.72% |
| 2023 FY | - INR | 31.88% |
| 2023 Q1 | 2.05 Billion INR | 5.88% |
| 2023 Q4 | 2.18 Billion INR | -8.78% |
| 2023 Q2 | 2.39 Billion INR | 16.23% |
| 2023 Q3 | 2.39 Billion INR | 0.16% |
| 2022 Q2 | 1.73 Billion INR | 21.79% |
| 2022 FY | - INR | 38.99% |
| 2022 Q4 | 1.94 Billion INR | -88.88% |
| 2022 Q3 | 17.47 Billion INR | 907.0% |
| 2022 Q1 | 1.42 Billion INR | 105.26% |
| 2021 Q4 | -27.09 Billion INR | -283.59% |
| 2021 Q1 | 1.07 Billion INR | 0.0% |
| 2021 Q3 | 14.75 Billion INR | 0.0% |
| 2021 FY | - INR | 110.5% |
| 2020 FY | - INR | -2.92% |
| 2019 FY | - INR | 38.53% |
| 2018 FY | - INR | 19.32% |
| 2017 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 24.02 Billion INR | 63.705% |
| Artemis Medicare Services Limited | 1.24 Billion INR | -599.717% |
| Aster DM Healthcare Limited | 6.11 Billion INR | -42.554% |
| Fortis Healthcare Limited | 13.07 Billion INR | 33.319% |
| HealthCare Global Enterprises Limited | 3.5 Billion INR | -148.783% |
| Indraprastha Medical Corporation Limited | 2.1 Billion INR | -314.657% |
| Krishna Institute of Medical Sciences Limited | 6.61 Billion INR | -31.888% |
| Lotus Eye Hospital and Institute Limited | 79.42 Million INR | -10876.732% |
| Max Healthcare Institute Limited | 16.7 Billion INR | 47.801% |
| Max India Limited | -353.8 Million INR | 2564.135% |
| Narayana Hrudayalaya Limited | 12.42 Billion INR | 29.835% |
| Rainbow Children's Medicare Limited | 4.69 Billion INR | -85.72% |
| Shalby Limited | 1.98 Billion INR | -340.2% |